Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM
Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM
Recruiting · NCT05594797 · Registry updated 2022-12-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Human BCMA Targeted T Cells Injection（BCMA CAR-T）for Subjects With R/R MM | Blood Protein Disorders, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2022-12-09 | NCT05594797 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Affiliated Hospital of Wenzhou Medical University | 117 |
| Hrain Biotechnology Co., Ltd. | 6 |
| Shanghai Changzheng Hospital | 79 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Changzheng Hospital | Shanghai | China | 20 |
| The First Affiliated Hospital of Wenzhou Medical University | Wenzhou | China | 87 |